Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Non-Current Assets (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Non-Current Assets for 4 consecutive years, with $909000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 9.37% to $909000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.6 million, a 37.28% decrease, with the full-year FY2025 number at $909000.0, down 9.37% from a year prior.
  • Non-Current Assets was $909000.0 for Q4 2025 at Spruce Biosciences, up from $797000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $19.9 million in Q1 2022 to a low of $797000.0 in Q3 2025.
  • A 4-year average of $3.1 million and a median of $1.7 million in 2023 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: tumbled 90.56% in 2023, then dropped 9.37% in 2025.
  • Spruce Biosciences' Non-Current Assets stood at $2.0 million in 2022, then fell by 13.58% to $1.8 million in 2023, then tumbled by 43.11% to $1.0 million in 2024, then dropped by 9.37% to $909000.0 in 2025.
  • Per Business Quant, the three most recent readings for SPRB's Non-Current Assets are $909000.0 (Q4 2025), $797000.0 (Q3 2025), and $867000.0 (Q2 2025).